chr17-39909987-T-C

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_001165958.2(GSDMB):c.408-63A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.483 (AC=611,763) in the gnomAD database across 1,265,582 control chromosomes, including 150,310 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.5. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.48 ( 17511 hom., cov: 32)
Exomes 𝑓: 0.48 ( 132799 hom. )

Consequence

GSDMB
NM_001165958.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.18

Publications

181 publications found
Variant links:
Genes affected
GSDMB (HGNC:23690): (gasdermin B) This gene encodes a member of the gasdermin-domain containing protein family. Other gasdermin-family genes are implicated in the regulation of apoptosis in epithelial cells, and are linked to cancer. Alternative splicing and the use of alternative promoters results in multiple transcript variants. Additional variants have been described, but they are candidates for nonsense-mediated mRNA decay (NMD) and are unlikely to be protein-coding. [provided by RefSeq, Nov 2016]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001165958.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.4998 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001165958.2. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

GSDMB NM_001165958.2
MANE Select
HGVSc / HGVSpc.408-63A>G
Exon rankIntron 3 of 10
intron
Prot: NP_001159430.1UniProt: Q8TAX9-4
GSDMB NM_001388420.1
HGVSc / HGVSpc.408-63A>G
Exon rankIntron 2 of 9
intron
Prot: NP_001375349.1UniProt: Q8TAX9-4
GSDMB NM_001165959.2
HGVSc / HGVSpc.408-63A>G
Exon rankIntron 3 of 9
intron
Prot: NP_001159431.1UniProt: Q8TAX9-6

Ensembl Transcripts

GSDMB ENST00000418519.6
TSL:5MANE Select
HGVSc / HGVSpc.408-63A>G
Exon rankIntron 3 of 10
intron
Prot: ENSP00000415049.1UniProt: Q8TAX9-4
GSDMB ENST00000360317.7
TSL:1
HGVSc / HGVSpc.408-63A>G
Exon rankIntron 2 of 9
intron
Prot: ENSP00000353465.3UniProt: Q8TAX9-4
GSDMB ENST00000394179.5
TSL:1
HGVSc / HGVSpc.408-63A>G
Exon rankIntron 2 of 8
intron
Prot: ENSP00000377733.2UniProt: Q8TAX9-3

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.477
AC:72467
Hom:17464
AN:151890
Cov:32
GnomAD4 exome
AF: 0.484
AC:539188
Hom:132799
AN:1113574
GnomAD4 genome
AF: 0.477
AC:72575
Hom:17511
AN:152008
Cov:32
TOPMed (Bravo)
AF: 0.461
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.486
AC:325458
Hom:79329
AN:670310
Local & regional cohorts 9 sources
ABraOM SABE-WGS-1171
AF: 0.439
AC:1029
Hom:228
AN:2342
ChinaMAP Phase 1
AF: 0.273
Denmark Genome
AF: 0.513
AC:154
AN:300
GenomeAsia100K
AF: 0.417
AC:1448
AN:3478
Korea4K (4,157 Koreans)
AF: 0.265
AC:1920
AN:7234
Qatari Genome
AF: 0.557
AC:98
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.266
AC:32539
Hom:4343
AN:122366
UK10K
AF: 0.506
AC:3824
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.259
AC:2318
Hom:311
AN:8960
Showing 14 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.381 2541466622 0.396 50263126826
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign4.6
BayesDel_noAF
Benign-0.98
CADD
Benign0.71
DANN
Benign0.35
GPN-Star LLR
N/A5.4
GPN-Star score
N/A0.33
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign-1.2
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.020
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

dbSNP: rs2290400;
hg19: chr17-38066240;
COSMIC: COSV58783257;
COSMIC: COSV58783257;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.